glp-1 receptor agonist after roux-en-y gastric bypass Interest in Treatment with Agonists for the Management of Insufficient Weight Loss or Weight Regain Bariatric Surgery | Obesity Surgery Gastrointestinal effects of GLP-1 receptor

Nearly 20% of sites prescribed #GLP-1 receptor agonists based on upper-body photos alone

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

Dan McKees proposed fiscal year 2027 budget would remove GLP-1 drugs from Rhode Islands Medicaid formulary for weight loss, saving $6.3 million in general revenue

Here is a list of approved and pending new GLP-1 agonists class of medications that can help manage Type 2 diabetes and obesity.

PlexusDx provides access to compounded semaglutide starting at $149/month through licensed pharmacies

This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database